Thu, July 29, 2021

Kennen MacKay Maintained (BMRN) at Hold with Increased Target to $88 on, Jul 29th, 2021

Kennen MacKay of RBC Capital, Maintained "BioMarin Pharmaceutical Inc." (BMRN) at Hold with Increased Target from $87 to $88 on, Jul 29th, 2021.

Kennen has made no other calls on BMRN in the last 4 months.



There is 1 other peer that has a rating on BMRN. Out of the 1 peers that are also analyzing BMRN, all agrees with Kennen's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Matthew Harrison of "Morgan Stanley" Maintained at Hold with Decreased Target to $82 on, Monday, April 19th, 2021